|
|
|
A certain type of adverse drug reaction could be predicted by using gene screening, a Brief Communication in the 01 April 2004 issue of Nature (Vol. 428, No. 6982, p. 486) suggests.
Yuan-Tsong Chen and colleagues studied the genetic make-up of 44 Han Chinese patients with a form of Stevens-Johnson syndrome (SJS) - a potentially life-threatening condition associated with extreme skin inflammation and triggered by the seizure-calming drug carbamazepine. The team found that sufferers all carry the same variant of a particular gene, whereas people without this genetic 'marker' do not react against the drug. The discovery should enable researchers to formulate a predictive genetic test for carbamazepine-induced SJS in Chinese populations, and aid understanding of the condition itself. CONTACT: Yuan-Tsong Chen
Institute of Biomedical Sciences
Academia Sinica
Taipei, Taiwan
Tel: +1 886 2 2789 9104
E-mail: chen0010@ibms.sinica.edu.tw (C) Nature press release.
Message posted by: Trevor M. D'Souza
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|